Statements (65)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Genetics
|
| gptkbp:allows |
gene replacement
gene insertion gene knockout targeted gene modification |
| gptkbp:based_on |
gptkb:CRISPR-Cas9
|
| gptkbp:business_model |
biodiversity loss
designer babies gene editing in humans |
| gptkbp:challenges |
traditional breeding methods
conventional genetic engineering |
| gptkbp:developed_by |
gptkb:Emmanuelle_Charpentier
gptkb:Jennifer_Doudna |
| gptkbp:future_prospects |
improve food security
cure genetic diseases enhance crop resilience create new therapies |
| gptkbp:has_applications_in |
gptkb:biotechnology
genetic disorders cancer research agricultural improvements |
| https://www.w3.org/2000/01/rdf-schema#label |
CRISPR technology
|
| gptkbp:is |
gptkb:revolution
|
| gptkbp:is_advancing_in |
personalized medicine
vaccine development therapeutic applications pathogen research |
| gptkbp:is_based_on |
bacterial immune system
|
| gptkbp:is_criticized_for |
unintended consequences
ethical implications potential misuse |
| gptkbp:is_part_of |
molecular biology
modern genetics biomedical research synthetic biology research |
| gptkbp:is_promoted_by |
gptkb:scientific_community
biotechnology companies research institutions |
| gptkbp:is_regulated_by |
government agencies
ethical committees |
| gptkbp:is_studied_for |
gptkb:cystic_fibrosis
gptkb:sickle_cell_disease gptkb:Fuchsia gptkb:muscular_dystrophy gptkb:neurodegenerative_diseases HIV treatment various cancers |
| gptkbp:is_supported_by |
pharmaceutical companies
government funding venture capitalists Cas9 protein guide RNA |
| gptkbp:is_used_in |
clinical trials
agricultural biotechnology |
| gptkbp:used_in |
gptkb:biotechnology
gptkb:Medicine agriculture genome editing gene editing |
| gptkbp:bfsParent |
gptkb:Emmanuelle_Charpentier
gptkb:DNA gptkb:University_of_California,_Berkeley gptkb:Jennifer_Doudna gptkb:Mario_Capecchi |
| gptkbp:bfsLayer |
3
|